CD11c+ CD8+ T cells had a higher activation state and higher secretory and cytotoxic capacity with a lower level of exhaustion marker in controlling HIV-1 infection, indicating a potential treatment efficacy in HIV-1-infected patients. The gene discussed is ITGAX; the disease is HIV-1 infection.